Article
The FDA has approved what is said to be the first soft artificial cornea (AlphaCor, Argus Biomedical Pty. Ltd., Perth, Western Australia) for sale in the United States.
Investigators highlight the risk of misdiagnosing geographic atrophy
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
Aflibercept treat-and-extend regimen for neovascular AMD: 5-year outcomes
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
Bausch + Lomb announces launch of new intelligent Arise lens fitting system
FDA approves expanded label for fluocinolone acetonide intravitreal implant